KR100614220B1 - Flt3 리간드 유전자를 발현하는 살모넬라 균주 및 이를함유하는 항암 치료용 조성물 - Google Patents
Flt3 리간드 유전자를 발현하는 살모넬라 균주 및 이를함유하는 항암 치료용 조성물 Download PDFInfo
- Publication number
- KR100614220B1 KR100614220B1 KR1020040090530A KR20040090530A KR100614220B1 KR 100614220 B1 KR100614220 B1 KR 100614220B1 KR 1020040090530 A KR1020040090530 A KR 1020040090530A KR 20040090530 A KR20040090530 A KR 20040090530A KR 100614220 B1 KR100614220 B1 KR 100614220B1
- Authority
- KR
- South Korea
- Prior art keywords
- salmonella
- flt3 ligand
- cancer
- ligand gene
- strain
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
- FLT3 리간드 유전자를 함유한 발현벡터 pcDNA3로 형질도입된 항암치료용 살모넬라 균주(Salmonella typhimurium) KCCM-10604.
- 제1항의 살모넬라 균주 KCCM-10604를 함유하는 것을 특징으로 하는 항암치료용 조성물.
- 제2항에 있어서, 상기 암의 종류는 피부암임을 특징으로 하는 항암치료용 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040090530A KR100614220B1 (ko) | 2004-11-08 | 2004-11-08 | Flt3 리간드 유전자를 발현하는 살모넬라 균주 및 이를함유하는 항암 치료용 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040090530A KR100614220B1 (ko) | 2004-11-08 | 2004-11-08 | Flt3 리간드 유전자를 발현하는 살모넬라 균주 및 이를함유하는 항암 치료용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060041063A KR20060041063A (ko) | 2006-05-11 |
KR100614220B1 true KR100614220B1 (ko) | 2006-08-21 |
Family
ID=37147806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040090530A KR100614220B1 (ko) | 2004-11-08 | 2004-11-08 | Flt3 리간드 유전자를 발현하는 살모넬라 균주 및 이를함유하는 항암 치료용 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100614220B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100818144B1 (ko) | 2006-02-15 | 2008-03-31 | 고려대학교 산학협력단 | 인터페론감마를 발현하는 살모넬라 균주 및 이를 함유하는항암 치료용 조성물 |
KR20230112200A (ko) | 2022-01-19 | 2023-07-27 | 록야 주식회사 | 새싹인삼에서 분리한 락토바실러스 람노서스 b3421 및 이를 포함하는 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030185802A1 (en) | 2002-03-02 | 2003-10-02 | Reisfeld Ralph A. | DNA vaccine against proliferating endothelial cells and methods of use thereof |
KR20040079421A (ko) * | 1995-10-04 | 2004-09-14 | 임뮤넥스 코포레이션 | 수지상 세포 자극 인자 |
-
2004
- 2004-11-08 KR KR1020040090530A patent/KR100614220B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040079421A (ko) * | 1995-10-04 | 2004-09-14 | 임뮤넥스 코포레이션 | 수지상 세포 자극 인자 |
US20030185802A1 (en) | 2002-03-02 | 2003-10-02 | Reisfeld Ralph A. | DNA vaccine against proliferating endothelial cells and methods of use thereof |
Non-Patent Citations (1)
Title |
---|
논 문 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100818144B1 (ko) | 2006-02-15 | 2008-03-31 | 고려대학교 산학협력단 | 인터페론감마를 발현하는 살모넬라 균주 및 이를 함유하는항암 치료용 조성물 |
KR20230112200A (ko) | 2022-01-19 | 2023-07-27 | 록야 주식회사 | 새싹인삼에서 분리한 락토바실러스 람노서스 b3421 및 이를 포함하는 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20060041063A (ko) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2296797C (fr) | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee | |
Gu et al. | Outer membrane vesicles derived from E. coli as novel vehicles for transdermal and tumor targeting delivery | |
JP2002531050A (ja) | 抗メチオニンおよび抗ホモシステイン化学療法におけるメチオニナーゼの使用 | |
KR20080070901A (ko) | 튜머 네크로시스 팩터 알파를 진핵세포에서 발현하는플라스미드를 포함하는 살모넬라 균주 및 이를 함유하는항암 치료용 조성물 | |
JP2022542167A (ja) | C/EBPアルファsaRNAを使用する組成物および方法 | |
KR100900742B1 (ko) | 인간 간암 동물모델 및 이를 이용한 수지상세포-유래 간암면역치료제의 예방 및 치료 효능을 분석하는 방법 | |
JP2006518342A (ja) | Lk8タンパク質を有効成分として含む抗癌剤 | |
Li et al. | Mesenchymal stem cells in gastric cancer: vicious but hopeful | |
Liang et al. | Optimized attenuated Salmonella typhimurium suppressed tumor growth and improved survival in mice | |
CN110408634A (zh) | 一种非整合李斯特菌疫苗及抗肿瘤免疫应答方法 | |
Fujimoto | Gene therapy for liver cirrhosis | |
KR100614220B1 (ko) | Flt3 리간드 유전자를 발현하는 살모넬라 균주 및 이를함유하는 항암 치료용 조성물 | |
ES2343419T3 (es) | Vacuna quimiocina antigenica recombinante. | |
Cao et al. | The roles of tissue resident macrophages in health and cancer | |
KR100790376B1 (ko) | 종양괴사인자 알파를 발현하는 살모넬라 균주 및 이를함유하는 항암 치료용 조성물 | |
KR100818144B1 (ko) | 인터페론감마를 발현하는 살모넬라 균주 및 이를 함유하는항암 치료용 조성물 | |
CN103965302B (zh) | 一种重组超抗原seb突变体,其制备方法及应用 | |
CN1322135C (zh) | 细胞因子il-24真核表达载体的构建及应用 | |
CN102838679B (zh) | Her2‑neu抗原阳性肿瘤治疗性疫苗的制备及应用 | |
CN113842466B (zh) | 一种分子包裹萘莫司他及其在治疗三阴性乳腺癌中的应用 | |
Zhu et al. | CXC motif chemokine receptor type 4 disrupts blood-brain barrier and promotes brain metastasis through activation of the PI3K/AKT pathway in lung cancer | |
WO2005103088A1 (fr) | Proteine hybride vh-ldp-ae renforçant des anticorps a domaine unique | |
CN102146433A (zh) | 用于指导伊立替康类药物个体化治疗的基因组合 | |
He et al. | Reconstructing Tumor Microenvironment Using Photoresponsive Cyanobacteria to Reversal Chemoresistance for Robust Chemotherapy | |
CN113384682B (zh) | 蝎毒多肽Smp43在制备抗肿瘤药物的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130621 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140630 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151109 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160615 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170707 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180723 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190808 Year of fee payment: 14 |